Biodexa Pharmaceuticals

NASDAQ: BDRX · Real-Time Price · USD
7.08
0.04 (0.57%)
At close: Aug 15, 2025, 3:59 PM
7.00
-1.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Biodexa Pharmaceuticals Income Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
n/a 83K 381K 529K 699K 645K 578K 576K
Cost of Revenue
3.25M 2.25M 4.5M 4.95M 5.11M 5.06M 4.65M 5.83M
Gross Profit
-3.25M -2.17M -4.12M -4.42M -4.41M -4.41M -4.08M -5.25M
Operating Income
-9.2M -7.99M -8.01M -8.04M -7.57M -7.54M -7M -9.61M
Interest Income
88K 128K 42K 8K 24K 40K 44K 34K
Pretax Income
-5.98M -7.06M -7.49M -8.95M -8.49M -6.11M -6.11M -9M
Net Income
-5.73M -6.82M -7.08M -8.16M -7.66M -5.37M -5.46M -7.92M
Selling & General & Admin
3.79M 2.77M 3.03M 3.62M 3.18M 3.14M 2.95M 4.4M
Research & Development
5.44M 4M 4.07M 4.95M 5.11M 5.06M 4.65M 14.17M
Other Expenses
-3.28M -955K -955K n/a n/a n/a n/a n/a
Operating Expenses
5.95M 5.83M 3.51M 4.52M 4.05M 1.66M 1.99M 3.71M
Interest Expense
49K 49K n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a 8K
Cost & Expenses
9.2M 8.08M 8.01M 9.47M 9.16M 6.72M 6.64M 9.54M
Income Tax Expense
-250K -7K 406K 783K 832K 747K 646K 1.08M
Shares Outstanding (Basic)
61.95K 2.48K 30.00 7.00 1.00 1.00 1.00 1.00
Shares Outstanding (Diluted)
61.95K 2.48K 30.00 7.00 1.00 1.00 1.00 1.00
EPS (Basic)
-13.71M -13.46M -332K -3.19M -4.94M -3.46M -3.52M -5.12M
EPS (Diluted)
-13.71M -13.46M -332K -3.19M -4.94M -3.46M -3.52M -5.12M
EBITDA
-8.18M -5.54M -6.46M -7.88M -7.39M -7.35M -6.79M -8.87M
EBIT
-8.36M -5.74M -6.6M -8.04M -7.57M -7.54M -7M -9.61M
Depreciation & Amortization
185K 209K 146K 154K 177K 192K 213K 742K